Purna Pharmaceuticals NV

Based in PUURS, Belgium, and founded in 1986, Purna Pharmaceuticals NV operates as a producer of pharmaceutical products to meet GxP standards as per specific client's requirements. In December 2003, Purna Pharmaceuticals NV raised growth funding from Creafund. Purna Pharmaceuticals NV provides a variety of development services, such as pharmaceuticals, human and veterinary medical devices, and cosmetics. The company offers a variety of development laboratories, such as a GLP-compliant analytical laboratory that is for analytical development, formulation development, the IMP clinical phase, and API’s.

In addition, the firm provides manufacturing of a wide range of products including liquid, semi-solid, and powder.   Purna Pharmaceuticals generates revenue through contract development and manufacturing of liquid, semi‑solid, and powder pharmaceutical products, including formulation development, GMP manufacturing, and services for global pharma, biotech, NGO, and public‑sector clients. In February 2026, Ampersand acquired Purna Pharmaceuticals NV from Creafund. The acquisition enables Pharmaceuticals NV to enhance its innovation, quality, and capacity while expanding global pharmaceutical manufacturing services.